SAILIFE1,591.50

Sai Life Sciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABPPLPHARMANHNEULANDLABNATCOPHARMLALPATHLABCOHANCEMcap ₹33,705 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation138.6166.9
+ Finance Costs76.239.2
+ Interest Income-17.6-18.6
+ Share-based Payments2.52.1
+ Unrealised FX (Gain) / Loss5.0-9.5
+ Other Non-cash Items34.4-24.4
Changes in Working Capital
+ Inventories-31.4-32.1
+ Trade Receivables — Current-100.0-15.4
+ Other Financial Assets — Non-current2.4-13.1
+ Other Current Assets-157.9-102.0
+ Other Non-current Assets2.2-3.2
+ Trade Payables — Current105.932.7
+ Other Financial Liabilities — Current6.30.0
+ Other Financial Liabilities — Non-current41.50.0
+ Other Current Liabilities0.044.5
+ Other Non-current Liabilities0.014.8
Cash from Operating Activities
Profit Before Tax (per I/S)227.7466.2483.4
+ Total Adjustments (incl. Working Capital)108.081.9
Cash from Operations (pre-tax)335.7548.1
+ Income Taxes Paid21.638.9
Cash from Operating Activities314.0509.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)369.3593.0
+ Disp of Fixed Assets0.00.5
+ Disp of Investment Property0.50.0
+ Purchase of Investments (Equity / Debt)0.01.6
+ Acq of Subsidiaries / Businesses (net)0.10.0
+ Interest Received — Investing15.922.5
+ Other Inflows / (Outflows) — Investing-183.7176.1
Cash from Investing Activities-536.7-395.4
Cash from Financing Activities
+ Proceeds from Issue of Shares1,000.35.2
+ Proceeds from Borrowings53.425.5
+ Repayment of Borrowings623.858.9
+ Payment of Lease Liabilities76.084.8
+ Interest Paid52.510.8
Cash from Financing Activities301.4-123.7
Net Changes in Cash (pre-FX)78.8-10.0
+ Effect of FX Rate Changes on Cash0.30.8
Net Changes in Cash79.1-9.1
Reference Items
EBITDA405.7631.2658.2
EBITDA Margin %23.9428.7929.25
Free Cash Flow (CFO − Capex)-55.2-83.8-83.8
Free Cash Flow to Equity-128.1
Free Cash Flow per Basic Share-2.61-3.96-3.96
Cash Flow to Net Income1.851.46
Cash Paid for Taxes21.638.9
Cash Paid for Interest52.510.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.